A detailed history of Truist Financial Corp transactions in Enovis Corp stock. As of the latest transaction made, Truist Financial Corp holds 27,294 shares of ENOV stock, worth $1.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
27,294
Previous 23,904 14.18%
Holding current value
$1.2 Million
Previous $1.08 Million 8.8%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$40.57 - $48.1 $137,532 - $163,059
3,390 Added 14.18%
27,294 $1.18 Million
Q2 2024

Aug 20, 2024

BUY
$44.56 - $62.43 $451,882 - $633,102
10,141 Added 73.68%
23,904 $1.08 Million
Q1 2024

May 10, 2024

BUY
$55.44 - $63.8 $366,513 - $421,781
6,611 Added 92.44%
13,763 $859,000
Q4 2023

Feb 02, 2024

BUY
$43.67 - $57.07 $142,407 - $186,105
3,261 Added 83.81%
7,152 $400,000
Q3 2023

Nov 14, 2023

BUY
$51.65 - $65.54 $200,970 - $255,016
3,891 New
3,891 $205,000

Others Institutions Holding ENOV

About Enovis CORP


  • Ticker ENOV
  • Exchange NYSE
  • Sector Industrials
  • Industry Specialty Industrial Machinery
  • Shares Outstandng 54,129,500
  • Market Cap $2.38B
  • Description
  • Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat p...
More about ENOV
Track This Portfolio

Track Truist Financial Corp Portfolio

Follow Truist Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Truist Financial Corp with notifications on news.